Cart
sales@molnova.com
ADX-102
CAS No. 916056-79-6
ADX-102( Reproxalap | NS-2 )
Catalog No. M16578 CAS No. 916056-79-6
ADX-102 (Reproxalap, NS-2) is a novel small molecule immunomodulator that covalently binds aldehydes including malondialdehyde and 4-hydroxynonenal.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | In Stock |
|
| 5MG | 72 | In Stock |
|
| 10MG | 102 | In Stock |
|
| 25MG | 205 | In Stock |
|
| 50MG | 290 | In Stock |
|
| 100MG | 484 | In Stock |
|
| 500MG | 1035 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameADX-102
-
NoteResearch use only, not for human use.
-
Brief DescriptionADX-102 (Reproxalap, NS-2) is a novel small molecule immunomodulator that covalently binds aldehydes including malondialdehyde and 4-hydroxynonenal.
-
DescriptionADX-102 (Reproxalap, NS-2) is a novel small molecule immunomodulator that covalently binds aldehydes including malondialdehyde and 4-hydroxynonenal, which have been shown to mediate inflammatory pain; DX-102 is a promising agent for the treatment of dry eye disease.Allergy Phase 3 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsReproxalap | NS-2
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research AreaInflammation/Immunology
-
IndicationAllergy
Chemical Information
-
CAS Number916056-79-6
-
Formula Weight236.699
-
Molecular FormulaC12H13ClN2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(C)(C)C1=NC2=CC=C(Cl)C=C2C=C1N
-
Chemical Name2-(3-amino-6-chloroquinolin-2-yl)propan-2-ol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Rilmenidine Phosphat...
Rilmenidine Phosphate is a selective I(1) imidazoline receptor agonist, used to treat hypertension.
-
8-Prenylkaempferol
8-Prenylkaempferol is an effective agent for attenuating pro-inflammatory NO induction, it may be an anti-inflammatory agent for suppressing influenza A virus-induced RANTES production acts by blocking PI3K-mediated transcriptional activation of NF-κB and IRF-3 and in part by interfering with IκB degradation which subsequently decreases NF-κB translocation.
-
α-Gliadin (57–73)
α-Gliadin (57–73)
